US Celiac Disease Treatment Market Research Report: By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End User (Hospitals and Clinics, Research Centers, Others) - Forecast to 2035

US Celiac Disease Treatment Market Overview

As per MRFR analysis, the US Celiac Disease Treatment Market Size was estimated at 115.37 (USD Million) in 2023. The US Celiac Disease Treatment Market Industry is expected to grow from 128.1(USD Million) in 2024 to 853.71 (USD Million) by 2035. The US Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 18.819% during the forecast period (2025 - 2035).

Key US Celiac Disease Treatment Market Trends Highlighted

Celiac disease has gained significant attention in the US, leading to an increase in demand for effective treatments and management options. One of the key market drivers is the rising prevalence of celiac disease, with estimates suggesting that about 1 in 100 Americans are affected by this autoimmune disorder, prompting healthcare providers to focus on better diagnostic mechanisms and therapeutic approaches. Growing awareness among the general public, coupled with increased screening efforts by healthcare professionals, has contributed to the identification of undiagnosed cases, further driving treatment demand.

Opportunities in the US Celiac Disease Treatment Market are abundant, particularly in the development of alternative therapies beyond the traditional gluten-free diet.Research is ongoing into pharmacological treatments that can provide symptom relief and improve patients' quality of life for those who accidentally consume gluten. Companies focused on innovations in enzyme supplementation and the development of novel dietary products tailored for celiac patients are well-positioned to capture this growing market segment. Recent trends indicate a rise in the acceptance and availability of gluten-free products across retail and dining establishments, reflecting a shift in consumer preferences.

The US food industry is responding with a wider selection of gluten-free options, which enhances the quality of life for celiac patients.Furthermore, the increased collaboration between food manufacturers and health organizations is fostering the development of safe consumption practices and raising standards within the food industry. As celiac disease awareness grows, support networks and resources for patients continue to evolve, providing crucial information and community support that aids in the management of the condition. Overall, a combination of increasing prevalence, novel treatment opportunities, and changing consumer behavior denotes dynamic progress within the US Celiac Disease Treatment Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Celiac Disease Treatment Market Drivers

Increasing Awareness and Diagnosis of Celiac Disease

The growing awareness of celiac disease among healthcare professionals and the general public is significantly driving the US Celiac Disease Treatment Market Industry. According to data from the National Institutes of Health, it is estimated that only 30% of the individuals with celiac disease are currently diagnosed, implying that a substantial portion of the population remains undiagnosed. With the recent initiatives by the Celiac Disease Foundation to promote awareness and educate physicians, there has been a notable increase in diagnoses by approximately 7% annually over the past five years.

This rising diagnostic rate is contributing to the expanding treatment market as more individuals seek therapeutic options, fostering growth in the US Celiac Disease Treatment Market Industry, which is projected to thrive through increased patient demand for effective treatments.

Advancements in Treatment Options

There have been significant advancements in treatment options for celiac disease that are driving the US Celiac Disease Treatment Market Industry. New therapeutic methods, including enzyme therapies aimed at enhancing gluten digestion, are being developed and validated through ongoing Research and Development activities. According to the U.S. Food and Drug Administration, over 15 new treatments related to celiac disease have received investigational new drug status in the past three years, signaling a rapid evolution of the treatment landscape.

This offers patients more choices beyond the traditional gluten-free diet, which not only enhances patient outcomes but is also expected to significantly increase the overall market value.

Rising Prevalence of Celiac Disease

The increasing prevalence of celiac disease within the United States acts as a major driver for the US Celiac Disease Treatment Market Industry. Recent estimates from the Centers for Disease Control and Prevention indicate that prevalence rates have risen by 5% over the last decade, currently affecting approximately 1 in 133 individuals in the American population. This rise is encouraging greater research initiatives and driving the need for more comprehensive treatment options, contributing to market growth.

Organizations such as the American Gastroenterological Association are actively involved in advocating for improved celiac disease management strategies, thereby raising attention towards this condition and indirectly boosting the treatment market.

US Celiac Disease Treatment Market Segment Insights

Celiac Disease Treatment Market Treatment Type Insights

The US Celiac Disease Treatment Market encompasses a diverse range of Treatment Types, primarily focusing on Gluten Free Diet, Vitamin and Minerals Supplements, and Medical Therapies. Within this market, the Gluten Free Diet plays a pivotal role as the primary treatment approach, offering a dietary modification that is crucial for patients with celiac disease. Adhering to a strict gluten-free diet not only alleviates symptoms but also aids in healing the intestinal lining, which is vital for long-term health and well-being.

This dietary approach is widely recognized among healthcare professionals and patients alike as the cornerstone of celiac disease management, significantly impacting the development of numerous gluten-free products within the U.S. food industry. Vitamin and Minerals Supplements hold a significant position in the treatment realm, addressing the nutritional deficiencies commonly associated with celiac disease. Patients often suffer from malabsorption issues, leading to deficiencies in essential vitamins and minerals. Therefore, supplementation becomes a strategic intervention to restore nutritional balance and support overall health.

This aspect not only enhances patient quality of life but also fosters an ongoing demand for fortified products within the market, as awareness of nutritional needs continues to grow.Medical Therapies, while not the primary treatment, are gaining traction as research progresses. These therapies aim to provide additional options for patients who may struggle with strict dietary adherence or wish to mitigate symptoms more effectively. Ongoing Research and Development efforts are focusing on pharmaceutical solutions, which may offer innovative methods to manage celiac disease through mechanisms that reduce gluten-induced damage.

As the medical community becomes more adept at addressing the complexities of celiac disease, the potential for these therapies to reshape treatment paradigms grows, contributing to a more comprehensive management strategy.Overall, the segmentation within the US Celiac Disease Treatment Market reflects a multifaceted approach to managing the condition. The interplay between dietary management, supplementation, and emerging medical therapies underscores the importance of a holistic treatment plan that addresses the diverse needs of patients. This market's growth is driven by a combination of increasing awareness, evolving dietary habits, and advancements in medical options, resulting in a dynamic landscape that continues to adapt to the needs of individuals affected by celiac disease.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Celiac Disease Treatment Market End User Insights

The End User segment of the US Celiac Disease Treatment Market reflects a crucial landscape shaped by various healthcare providers, including Hospitals and Clinics, Research Centers, and Others. Hospitals and Clinics play a pivotal role as primary care settings where patients receive diagnoses and therapeutic interventions for celiac disease. Their accessibility and diverse treatment options cater to a significant patient base that seeks timely management of this autoimmune disorder. Research Centers contribute to the advancement of understanding and effective treatment strategies, fostering innovation through clinical trials and comprehensive studies on celiac disease.

This ongoing research significantly enhances the treatment landscape and provides additional avenues for patient care. Furthermore, the 'Others' category encompasses outpatient facilities, laboratories, and specialized practices, which collectively assist in addressing the unique needs of celiac patients. The growing awareness of celiac disease, along with an increased emphasis on gluten-free diets, continues to drive engagement across all these end user domains, leading to improved patient outcomes and quality of life. With a focus on tailored treatment approaches and continued research efforts, the US Celiac Disease Treatment Market stands poised for ongoing development across its End User segment.

US Celiac Disease Treatment Market Key Players and Competitive Insights

The US Celiac Disease Treatment Market is characterized by a growing awareness of gluten-related disorders and the increasing prevalence of celiac disease among the population. This has led to a surge in demand for gluten-free products and therapeutic options that cater specifically to individuals diagnosed with this autoimmune condition. Companies operating within this market are focusing on innovation, product development, and strategic partnerships to enhance their offerings and capture greater market share. The competition is intensifying as businesses strive to meet the unique dietary needs of consumers while ensuring product quality and taste.

As healthcare providers increasingly recognize the importance of a gluten-free diet in managing celiac disease, the market presents a dynamic landscape for both established players and new entrants.Dr. Schär stands out in the US Celiac Disease Treatment Market due to its extensive range of gluten-free products designed to meet the dietary requirements of those affected by celiac disease. The company has a strong market presence, underpinned by its commitment to research and development, which enables it to offer high-quality, safe, and delicious gluten-free options. Dr. Schär is known for its diverse product line, which includes bread, pasta, snacks, and mixes.

One of its notable strengths is its consistent focus on maintaining high safety standards and transparent labeling. By prioritizing consumer education and health, Dr. Schär has built a loyal customer base and established itself as a trusted brand among consumers seeking celiac-friendly food alternatives in the US market.Hormel Foods plays a significant role in the US Celiac Disease Treatment Market with a solid focus on innovation and the development of gluten-free options within its product portfolio. The company has made strategic investments in the sector, aiming to expand its offerings and reach health-conscious consumers who require gluten-free diets due to celiac disease.

Hormel Foods has introduced key products that cater to this audience, including gluten-free snacks and meal solutions, emphasizing convenience and taste. The company's strengths lie in its established brand reputation and its ability to leverage its extensive distribution network, making gluten-free options more accessible to consumers across the United States. Hormel Foods has also been active in pursuing mergers and acquisitions to enhance its presence in the gluten-free market, thereby strengthening its position and expanding its reach in a competitive landscape.

Key Companies in the US Celiac Disease Treatment Market Include

• Dr. Schär


• Hormel Foods


• Takeda


• Tate and Lyle


• Gluten Free Holdings


• Boulder Brands


• Nestlé


• Diana Food


• Kraft Heinz


• Annie's


• AbbVie


• Pinnacle Foods


• General Mills


• Hain Celestial

US Celiac Disease Treatment Market Industry Developments

The US Celiac Disease Treatment Market has experienced significant developments recently, driven by an increasing prevalence of celiac disease and rising consumer demand for gluten-free products. Notable recent growth has been observed in companies such as Dr. Schär and Hormel Foods, which continue to expand their gluten-free product lines. In September 2023, Takeda announced an uptick in investment aimed at Research and Development for novel therapies, responding to a market increasingly focused on personalized medicine.

Additionally, Kraft Heinz and General Mills are actively improving their existing gluten-free product offerings to enhance market share. In August 2023, Tate and Lyle completed the acquisition of a smaller gluten-free ingredient company to strengthen its portfolio. The market’s valuation has been bolstered by increased awareness and stringent labeling regulations surrounding gluten-free products. Over the past few years, merger and acquisition activity, particularly by major players such as Nestlé and Pinnacle Foods, has amplified competition within the sector. The overall growth trajectory of this market underscores a commitment to innovative treatments and product development aimed at addressing the needs of those affected by celiac disease in the US.

US Celiac Disease Treatment Market Segmentation Insights

Celiac Disease Treatment Market Treatment Type Outlook

• Gluten Free Diet


• Vitamin and Minerals Supplements


• Medical Therapies

Celiac Disease Treatment Market End User Outlook

• Hospitals and Clinics


• Research Centers


• Others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	115.37(USD Million)
MARKET SIZE 2024	128.1(USD Million)
MARKET SIZE 2035	853.71(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	18.819% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Dr. Schär, Hormel Foods, Takeda, Tate and Lyle, Gluten Free Holdings, Boulder Brands, Nestlé, Diana Food, Kraft Heinz, Annie's, AbbVie, Pinnacle Foods, General Mills, Hain Celestial
SEGMENTS COVERED	Treatment Type, End User
KEY MARKET OPPORTUNITIES	Novel gluten-free products development, Digital health solutions integration, Personalized medicine advancements, Increased awareness and education campaigns, Expansion of clinical trials and research
KEY MARKET DYNAMICS	Increasing prevalence of celiac disease, Growing awareness and diagnosis rates, Rise in gluten-free product demand, Advancements in therapeutic options, Supportive government regulations and initiatives
COUNTRIES COVERED	US